PharmaShots Weekly Snapshot (March 30 - April 03, 2020)
1. Sorrento Initiates the Next Phase of its Collaboration with Celularity
Published: Apr 02, 2020 | Tags: Sorrento, Initiates, Next Phase, Collaboration, Celularity
2. ?? Celltrion Enters the Next Phase of Development for its Antiviral Therapy to Combat COVID-19 Pandemic
Published: Apr 03, 2020 | Tags: Celltrion, Enters, Next Phase, Development, Antiviral Therapy, Combat, COVID-19 Pandemic
Published: Apr 02, 2020 | Tags: Novartis, Incyte, Intend, Initiate, P-III, RUXCOVID, Study, Jakavi, ruxolitinib, Treatment, Patients, COVID-19, Associated, Cytokine Storm
4. Amgen and Adaptive Biotechnologies Collaborate to Develop Therapies Targeting COVID-19
Published: Apr 02, 2020 | Tags: Amgen, Adaptive Biotechnologies, Collaborate, Develop, Therapies, Targeting, COVID-19
5. ? Celularitys New Cell Therapy Receives the US FDAs IND Approval for COVID-19
Published: Apr 02, 2020 | Tags: Cellularity, Receives, US, FDA, Approval, IND, New Cell Therapy, COVID-19
Published: Apr 02, 2020 | Tags: Pfizer, Ruxience, biosimilar, rituximab, Receives, EC, Approval, Cancer, Autoimmune Diseases
Published: Apr 02, 2020 | Tags: Vir, Alnylam, Expand, Existing, Collaboration, Develop, RNAi Therapeutics, Targeting, Host Factors, COVID-19
Published: Apr 02, 2020 | Tags: Merck, Reports, Results, Keytruda, pembrolizumab, P-III, KEYNOTE-177, Study, Advanced Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer
9. Gilead Initiates Two P-III Studies Evaluating Remdesivir (GS-5734) for COVID-19 in the UK
Published: Apr 02, 2020 | Tags: Gilead, Initiates, Two, P-III, Studies, Evaluating, Remdesivir, COVID-19, UK
10. FDA Launches Emergency Program to Expedite the Development of COVID-19 Treatments
Published: Apr 01, 2020 | Tags: FDA, Launches, Emergency Program, Expedite, Development, COVID-19, Treatments
Published: Apr 01, 2020 | Tags: Y-mAbs, Reports, Submission, Naxitamab, BLA, US, FDA, Relapsed/Refractory, High-Risk Neuroblastoma
12. Three Global Pharmaceutical Companies Launch Worker Volunteer Programs to Combat COVID-19
Published: Apr 01, 2020 | Tags: Three, Global Pharmaceutical Companies, Launch, Worker Volunteer Programs, Combat, COVID-19
13. BD and BioMedomics Launch Rapid Serology Test to Detect Exposure to COVID-19 in 15 Minutes
Published: Mar 31, 2020 | Tags: BD, BioMedomics, Launch, Rapid Serology Test, Detect, Exposure, COVID-19, 15 Minutes
Published: Mar 31, 2020 | Tags: QIAGEN, QIAstat-Dx Test Kit, Receives, US, FDA, EUA, First Syndromic Test, Detect, COVID-19
Published: Mar 31, 2020 | Tags: Daiichi Sankyo, Signs, Non-Exclusive, License Agreement, Ultragenyx, Gene Therapy Manufacturing Technology
16. ?? Amgen Repurchases Astellas Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan
Published: Mar 31, 2020 | Tags: Amgen, Purchases, Shares, Amgen Astellas BioPharma, Strengthen, Presence, Japan
Published: Apr 01, 2020 | Tags: VIVUS, Telemedicine, Remote Monitoring Modules, Effective, Patient Care, During, COVID-19
18. Amgen Provides Update on its Clinical Activities and Medicine Supply Amid COVID-19 Pandemic
Published: Apr 01, 2020 | Tags: Amgen, Provides, Update, Clinical Activities, Medicine Supply, Amid, COVID19 Pandemic
Published: Mar 31, 2020 | Tags: Sorrento, University of Texas Medical Branch, Collaborate, Preclinical Testing, COVID-19, Therapeutic Candidates
Published: Mar 31, 2020 | Tags: Lilly, Signs, Worldwide, License, Research Agreement, Sitryx, Develop, New Immunometabolic Therapies
Published: Mar 31, 2020 | Tags: AstraZeneca, Lokelma, Receives, CHMP, Recommendation, Approval, Patients, Hyperkalemia, Stable, Hemodialysis
22. The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19
Published: Mar 30, 2020 | Tags: US, FDA, Authorizes, Emergency Use, Antimalarial Drugs, Combat, COVID-19
Published: Mar 30, 2020 | Tags: Bayer, Nubeqa, darolutamide, Receives, EC, Approval, Men, Non-Metastatic Castration-Resistant Prostate Cancer
Published: Mar 27, 2020 | Tags: Abbott, Receives, FDA, Emergency Use Authorization, Point-Of-Care Test, Detect, Novel, COVID-19, Five Minutes
25. ?Johnson & Johnson and BARDA to Fund ~$1B in Research and Development of Novel COVID-19 Vaccines
Published: Mar 30, 2020 | Tags: Johnson & Johnson, BARDA, Fund, ~$1B, Research, Development, Novel, COVID-19 Vaccines
Published: Mar 30, 2020 | Tags: BMS, Zeposia, ozanimod, Receives, CHMP, Positive Opinion, Adults, Relapsing, Remitting, Multiple Sclerosis, Active Disease
Published: Mar 30, 2020 | Tags: Eli Lilly, Taltz, ixekizumab, Receives, US, FDA, Approval, Treatment, Pediatric Patients, Moderate to Severe, Plaque Psoriasis
Published: Mar 30, 2020 | Tags: AstraZeneca, Imfinzi, durvalumab, Receives, US, FDA, Approval, Extensive-Stage Small Cell Lung Cancer
29. Mylan and Lupin Receive CHMPs Positive Opinion for Nepexton (biosimilar, etanercept)
Published: Mar 27, 2020 | Tags: Mylan, Lupin, Receive, CHMP, Positive Opinion, Nepexton, biosimilar, etanercept
Published: Mar 30, 2020 | Tags: Sanofi, Regeneron, Expand, Clinical Program, Kevzara, sarilumab, Treatment, COVID-19, Outside the US
31. Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19
Published: Mar 27, 2020 | Tags: Sanofi, Collaborates, Translate Bio, Develop, Novel, mRNA Vaccine, Against, COVID-19
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com